Sharps Technology Receivables 2022-2025 | STSS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sharps Technology receivables from 2022 to 2025. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sharps Technology receivables from 2022 to 2025. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$233.7B
Boston Scientific (BSX)	$152.8B
Stryker (SYK)	$144.4B
EssilorLuxottica (ESLOY)	$136.8B
Medtronic (MDT)	$119.1B
Lonza Group Ag (LZAGY)	$47.4B
Haleon (HLN)	$42.9B
ResMed (RMD)	$41.6B
GE HealthCare Technologies (GEHC)	$32.9B
Agilent Technologies (A)	$32.6B
Terumo (TRUMY)	$27.5B
Koninklijke Philips (PHG)	$25.8B
Insulet (PODD)	$21.6B
Zimmer Biomet Holdings (ZBH)	$19.7B
Smith & Nephew SNATS (SNN)	$15.8B
Baxter (BAX)	$12.2B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$7.2B
Lantheus Holdings (LNTH)	$3.9B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.4B
Prestige Consumer Healthcare (PBH)	$3.2B
Perrigo (PRGO)	$3.1B
ICU Medical (ICUI)	$2.8B
Haemonetics (HAE)	$2.6B
LeMaitre Vascular (LMAT)	$2.1B
AtriCure (ATRC)	$1.8B
QuidelOrtho (QDEL)	$1.6B
Green Thumb Industries (GTBIF)	$1.5B